Streptavidin-HRP

Set of 5 vials enough for 75 plates total
Catalog # Availability Size / Price Qty
DY998
Streptavidin-HRP
1 Image
Product Details
Citations (79)
FAQs
Supplemental Products
Reviews (18)

Streptavidin-HRP Summary

INTENDED USE & DESCRIPTION

Streptavidin-HRP (Part # 890803) contains 5 vials (1 mL/vial) of streptavidin conjugated to horseradish peroxidase for use with biotinylated detection antibodies in ELISAs and Western Blotting.

STORAGE & STABILITY

Store unopened at 2-8 °C. Stable for up to 6 months after opening when stored at 2-8 °C. Do Not Freeze.

REAGENT PREPARATION

For use in ELISAs, dilute to the working concentration specified on the vial label using 1% BSA/PBS or Reagent Diluent Concentrate 2 (Catalog # DY995) diluted 1:10 in deionized water. For use in Western blots, the suggested dilution is 1:200-1:2000 in an appropriate diluent. Use the diluted reagent within 60 minutes. 

Specifications

Shipping Conditions
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Applications
ELISA

Product Datasheets

Citations for Streptavidin-HRP

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

79 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Perturbation of the Actin Cytoskeleton in Human Hepatoma Cells Influences Interleukin-6 (IL-6) Signaling, but Not Soluble IL-6 Receptor Generation or NF-kappaB Activation
    Authors: E Georgieva, SL Leber, C Wex, C Garbers
    International Journal of Molecular Sciences, 2021;22(13):.  2021
  2. Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial alpha1AMPK
    Authors: M Angé, J De Poorter, A Ginion, S Battault, M Dechamps, GG Muccioli, M Roumain, J Morelle, S Druart, T Mathivet, L Bertrand, D Castanares, S Horman, C Beauloye
    Scientific Reports, 2021;11(1):13700.  2021
  3. Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
    Authors: BH Kang, N Momin, KD Moynihan, M Silva, Y Li, DJ Irvine, KD Wittrup
    PLoS ONE, 2021;16(4):e0248903.  2021
  4. Split Enzyme-Based Biosensors for Structural Characterization of Soluble and Insoluble &beta-Glucans
    Authors: D Yamanaka, S Kurita, Y Hanayama, Y Adachi
    International Journal of Molecular Sciences, 2021;22(4):.  2021
  5. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma
    Authors: JI Alexander, DB Vendramini, R Francescon, T Luong, J Franco-Bar, N Shah, JC Gardiner, E Nicolas, KS Raghavan, E Cukierman
    Scientific Reports, 2021;11(1):3802.  2021
  6. House dust mite sensitization drives cross-reactive immune responses to homologous helminth proteins
    Authors: PH Gazzinelli, S Bennuru, R de Queiroz, A Ricciardi, J Sciurba, J Kupritz, M Moser, O Kamenyeva, TB Nutman
    PloS Pathogens, 2021;17(3):e1009337.  2021
  7. &alpha1AMP-Activated Protein Kinase Protects against Lipopolysaccharide-Induced Endothelial Barrier Disruption via Junctional Reinforcement and Activation of the p38 MAPK/HSP27 Pathway
    Authors: M Angé, D Castanares, J De Poorter, C Dufeys, GE Courtoy, C Bouzin, R Quarck, L Bertrand, C Beauloye, S Horman
    Int J Mol Sci, 2020;21(15):.  2020
  8. New Paradigms to Assess Consequences of Long-Term, Low-Dose Curcumin Exposure in Lung Cancer Cells
    Authors: G Smagurausk, J Mahale, K Brown, AL Thomas, LM Howells
    Molecules, 2020;25(2):.  2020
  9. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
    Authors: C Yi, X Sun, J Ye, L Ding, M Liu, Z Yang, X Lu, Y Zhang, L Ma, W Gu, A Qu, J Xu, Z Shi, Z Ling, B Sun
    Cell. Mol. Immunol., 2020;0(0):.  2020
  10. Development of a novel &beta-1,6-glucan-specific detection system using functionally-modified recombinant endo-&beta-1,6-glucanase
    Authors: D Yamanaka, K Takatsu, M Kimura, M Swamydas, H Ohnishi, T Umeyama, F Oyama, MS Lionakis, N Ohno
    J. Biol. Chem., 2020;295(16):5362-5376.  2020
  11. Clinical and Analytical Validation of a Novel Urine-Based Test for the Detection of Allograft Rejection in Renal Transplant Patients
    Authors: N Nolan, K Valdivieso, R Mani, JYC Yang, RD Sarwal, P Katzenbach, K Chalasani, D Hongo, G Lugtu, C Mark, E Chen, R Nijor, D Savoca, DS Wexler, T Whitson, SJ Huang, LH Lu, RJX Zawada, E Hytopoulos, MM Sarwal
    J Clin Med, 2020;9(8):.  2020
  12. ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer�patients undergoing therapy with trastuzumab
    Authors: V Agnolon, A Contato, A Meneghello, E Tagliabue, G Toffoli, M Gion, F Polo, ASC Fabricio
    Sci Rep, 2020;10(1):3016.  2020
  13. Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology
    Authors: W Lin, WC Liang, T Nguy, M Maia, T Tyagi, C Chiu, KH Hoi, Y Chen, Y Wu
    PLoS ONE, 2020;15(12):e0244158.  2020
  14. 3D Bioprinting of osteochondral tissue substitutes - in vitro-chondrogenesis in multi-layered mineralized constructs
    Authors: D Kilian, T Ahlfeld, AR Akkineni, A Bernhardt, M Gelinsky, A Lode
    Sci Rep, 2020;10(1):8277.  2020
  15. An ultrasensitive hybridization chain reaction-amplified CRISPR-Cas12a aptasensor for extracellular vesicle surface protein quantification
    Authors: S Xing, Z Lu, Q Huang, H Li, Y Wang, Y Lai, Y He, M Deng, W Liu
    Theranostics, 2020;10(22):10262-10273.  2020
  16. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival
    Authors: JYC Yang, SE Verleden, A Zarinsefat, BM Vanaudenae, R Vos, GM Verleden, RD Sarwal, TK Sigdel, JM Liberto, I Damm, D Watson, MM Sarwal
    J Clin Med, 2019;8(2):.  2019
  17. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy
    Authors: M Verma, Y Shimizu-Mo, Y Asakura, JP Ennen, J Bosco, Z Zhou, GH Fong, S Josiah, D Keefe, A Asakura
    PLoS Genet., 2019;15(12):e1008468.  2019
  18. Engineering of CHO cells for the production of vertebrate recombinant sialyltransferases
    Authors: B Houeix, MT Cairns
    PeerJ, 2019;7(0):e5788.  2019
  19. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage
    Authors: CH Chao, WC Wu, YC Lai, PJ Tsai, GC Perng, YS Lin, TM Yeh
    PLoS Pathog., 2019;15(4):e1007625.  2019
  20. Cecropia obtusa extract and chlorogenic acid exhibit anti aging effect in human fibroblasts and keratinocytes cells exposed to UV radiation
    Authors: GAD Alves, R Oliveira d, HL Ghislain R, H Masaki, MJV Fonseca
    PLoS ONE, 2019;14(5):e0216501.  2019
  21. Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
    Authors: J Russick, S Delignat, P Milanov, O Christophe, G Boros, CV Denis, PJ Lenting, SV Kaveri, S Lacroix-De
    Haematologica, 2019;0(0):.  2019
  22. Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells
    Authors: D Karpova, MP Rettig, J Ritchey, D Cancilla, S Christ, L Gehrs, E Chendamara, MO Evbuomwan, M Holt, J Zhang, G Abou-Ezzi, H Celik, E Wiercinska, W Yang, F Gao, LG Eissenberg, RF Heier, SD Arnett, MJ Meyers, MJ Prinsen, DW Griggs, A Trumpp, PG Ruminski, DM Morrow, HB Bonig, DC Link, JF DiPersio
    J. Clin. Invest., 2019;129(7):2745-2759.  2019
  23. A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation
    Authors: XN Zhang, Q Cheng, J Chen, AT Lam, Y Lu, Z Dai, H Pei, NM Evdokimov, SG Louie, Y Zhang
    Nat Commun, 2019;10(1):4196.  2019
  24. Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
    Authors: SM Chin, CR Kimberlin, Z Roe-Zurz, P Zhang, A Xu, S Liao-Chan, D Sen, AR Nager, NS Oakdale, C Brown, F Wang, Y Yang, K Lindquist, YA Yeung, S Salek-Arda, J Chaparro-R
    Nat Commun, 2018;9(1):4679.  2018
  25. Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women
    Authors: C Engdahl, A Bondt, U Harre, J Raufer, R Pfeifle, A Camponesch, M Wuhrer, M Seeling, IL Mårtensson, F Nimmerjahn, G Krönke, HU Scherer, H Forsblad-d, G Schett
    Arthritis Res. Ther., 2018;20(1):84.  2018
  26. Impact of immunization against OxLDL on the pulmonary response to cigarette smoke exposure in mice
    Authors: M Talbot, M Hamel-Auge, MJ Beaulieu, M Gazzola, A Lechasseur, S Aubin, MÈ Paré, D Marsolais, Y Bossé, MC Morissette
    Respir. Res., 2018;19(1):131.  2018
  27. A systematic analysis of VRC01 antibody expression in Pichia pastoris through signal peptide optimization
    Authors: R Aw, PF McKay, RJ Shattock, KM Polizzi
    Protein Expr. Purif., 2018;0(0):.  2018
  28. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
    Authors: YL Lin, YH Chow, LM Huang, SM Hsieh, PY Cheng, KC Hu, BL Chiang
    Sci Rep, 2018;8(1):10713.  2018
  29. Vitronectin as a Micromanager of Cell Response in Material-Driven Fibronectin Nanonetworks
    Authors: M Cantini, K Gomide, V Moulisova, C González-G, M Salmerón-S
    Adv Biosyst, 2017;1(9):1700047.  2017
  30. A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies
    Authors: DI Bromage, S Taferner, M Pillai, DM Yellon, SM Davidson
    PLoS ONE, 2017;12(4):e0174447.  2017
  31. Inhibition of DNA replication by an anti-PCNA aptamer/PCNA complex
    Authors: E Kowalska, F Bartnicki, R Fujisawa, P Bonarek, P Hermanowic, T Tsurimoto, K Muszynska, W Strzalka
    Nucleic Acids Res., 2017;0(0):.  2017
  32. Exploring Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor Across Glaucoma Stages
    Authors: F Oddone, G Roberti, A Micera, A Busanello, S Bonini, L Quaranta, L Agnifili, G Manni
    PLoS ONE, 2017;12(1):e0168565.  2017
  33. Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection
    Authors: MC Patel, LM Pletneva, MS Boukhvalov, SN Vogel, AE Kajon, JCG Blanco
    Front Microbiol, 2017;8(0):1646.  2017
  34. Inhibitory Effects of Polyacetylene Compounds from Panax ginseng on Neurotrophin Receptor-Mediated Hair Growth
    Authors: A Suzuki, D Matsuura, H Kanatani, S Yano, M Tsunakawa, S Matsuyama, H Shigemori
    Biol. Pharm. Bull., 2017;40(10):1784-1788.  2017
  35. Hydrogels with precisely controlled integrin activation dictate vascular patterning and�permeability
    Authors: S Li, LR Nih, H Bachman, P Fei, Y Li, E Nam, R Dimatteo, ST Carmichael, TH Barker, T Segura
    Nat Mater, 2017;16(9):953-961.  2017
  36. Development of a Glycosaminoglycan Derived, Selectin Targeting Anti-Adhesive Coating to Treat Endothelial Cell Dysfunction
    Authors: JR Wodicka, AM Chambers, GS Sangha, CJ Goergen, A Panitch
    Pharmaceuticals (Basel), 2017;10(2):.  2017
  37. Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia
    PLoS ONE, 2016;11(11):e0164953.  2016
  38. Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis
    PLoS ONE, 2016;11(8):e0161465.  2016
  39. TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes.
    Authors: McKay P, King D, Mann J, Barinaga G, Carter D, Shattock R
    PLoS ONE, 2016;11(2):e0148984.  2016
  40. Impact of Histone H1 on the Progression of Allergic Rhinitis and Its Suppression by Neutralizing Antibody in Mice
    Authors: T Nakano, R Kamei, T Fujimura, Y Takaoka, A Hori, CY Lai, KC Chiang, Y Shimada, N Ohmori, T Goto, K Ono, CL Chen, S Goto, S Kawamoto
    PLoS ONE, 2016;11(4):e0153630.  2016
  41. A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1
    Genes Dev, 2016;30(9):1070-85.  2016
  42. Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction
    Authors: Tom J Parry
    Eur. J. Pharmacol, 2016;796(0):76-89.  2016
  43. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge
    PLoS ONE, 2016;11(8):e0161169.  2016
  44. Dendritic cells induce Th2-mediated airway inflammatory responses to house dust mite via DNA-dependent protein kinase.
    Authors: Mishra, Amarjit, Brown, Alexandr, Yao, Xianglan, Yang, Shutong, Park, Sung-Jun, Liu, Chengyu, Dagur, Pradeep, McCoy, J Philip, Keeran, Karen J, Nugent, Gayle Z, Jeffries, Kenneth, Qu, Xuan, Yu, Zu-Xi, Levine, Stewart, Chung, Jay H
    Nat Commun, 2015;6(0):6224.  2015
  45. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
    Authors: Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, Schaeren-Wiemers N, Du Pasquier R
    J Neuroinflammation, 2015;12(0):119.  2015
  46. The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent.
    Authors: Yates, Sharon C, Zafar, Amen, Rabai, Erzsebet, Foxall, James B, Nagy, Sheila, Morrison, Karen E, Clarke, Carl, Esiri, Margaret, Christie, Sharon, Smith, A David, Nagy, Zsuzsann
    PLoS ONE, 2015;10(1):e0114050.  2015
  47. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.
    Authors: Lee W, Shen S, Shih Y, Chou C, Tseng J, Chin S, Liu K, Chen Y, Jiang M
    J Transl Med, 2015;13(0):191.  2015
  48. One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.
    Authors: Costa-Pereira C, Moreira M, Soares R, Marteleto B, Ribeiro V, Franca-Dias M, Cardoso L, Viana K, Giunchetti R, Martins-Filho O, Araujo M
    BMC Vet Res, 2015;11(0):92.  2015
  49. Crucial role of IL1beta and C3a in the in vitro-response of multipotent mesenchymal stromal cells to inflammatory mediators of polytrauma.
    Authors: Hengartner N, Fiedler J, Schrezenmeier H, Huber-Lang M, Brenner R
    PLoS ONE, 2015;10(1):e0116772.  2015
  50. Upregulated interleukin-21 receptor on B cells associated with the downregulation of IgE in patients with allergic rhinitis.
    Authors: Jen, Hsiao-Yu, Yang, Yao-Hsu, Chiang, Bor-Luen, Chuang, Ya-Hui
    J Interferon Cytokine Res, 2015;35(1):42-8.  2015
  51. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
    Authors: Frehn L, Jansen A, Bennek E, Mandic A, Temizel I, Tischendorf S, Verdier J, Tacke F, Streetz K, Trautwein C, Sellge G
    PLoS ONE, 2014;9(9):e106750.  2014
  52. Genome-wide identification and quantification of protein synthesis in cultured cells and whole tissues by puromycin-associated nascent chain proteomics (PUNCH-P).
    Authors: Aviner, Ranen, Geiger, Tamar, Elroy-Stein, Orna
    Nat Protoc, 2014;9(4):751-60.  2014
  53. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants.
    Authors: Rossi O, Pesce I, Giannelli C, Aprea S, Caboni M, Citiulo F, Valentini S, Ferlenghi I, MacLennan C, D'Oro U, Saul A, Gerke C
    J Biol Chem, 2014;289(36):24922-35.  2014
  54. Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.
    Authors: McKay P, Cope A, Mann J, Joseph S, Esteban M, Tatoud R, Carter D, Reed S, Weber J, Shattock R
    PLoS ONE, 2014;9(1):e84707.  2014
  55. Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.
    Authors: Moelants, Eva A V, Loozen, Gitte, Mortier, Anneleen, Martens, Erik, Opdenakker, Ghislain, Mizgalska, Danuta, Szmigielski, Borys, Potempa, Jan, Van Damme, Jo, Teughels, Wim, Proost, Paul
    Infect Immun, 2014;82(6):2511-9.  2014
  56. Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.
    Authors: Winckelmann A, Munk-Petersen L, Rasmussen T, Melchjorsen J, Hjelholt T, Montefiori D, Ostergaard L, Sogaard O, Tolstrup M
    PLoS ONE, 2013;8(4):e62074.  2013
  57. A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in mice.
    Authors: Tregoning, John S, Buffa, Viviana, Oszmiana, Anna, Klein, Katja, Walters, Adam A, Shattock, Robin J
    PLoS ONE, 2013;8(11):e80559.  2013
  58. Proteome-wide screening reveals immunodominance in the CD8 T cell response against classical swine fever virus with antigen-specificity dependent on MHC class I haplotype expression.
    Authors: Franzoni G, Kurkure N, Essler S, Pedrera M, Everett H, Bodman-Smith K, Crooke H, Graham S
    PLoS ONE, 2013;8(12):e84246.  2013
  59. A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys.
    Authors: Ohshima-Hosoyama S, Simmons HA, Goecks N
    PLoS ONE, 2012;7(6):e39036.  2012
  60. Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen.
    Authors: King GD, Muhammad AK, Larocque D
    Mol. Ther., 2011;19(10):1793-801.  2011
  61. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells.
    Authors: Notley CA, Brown MA, Wright GP, Ehrenstein MR
    J. Immunol., 2011;186(8):4967-72.  2011
  62. IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression.
    Authors: Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, Ward NL, Wohn C, Prens EP, Wang F, Maier LE, Kang S, Voorhees JJ, Elder JT, Gudjonsson JE
    J. Immunol., 2011;186(4):2613-22.  2011
  63. Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs.
    Authors: Iversen MB, Ank N, Melchjorsen J, Paludan SR
    J. Virol., 2010;84(9):4579-86.  2010
  64. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke.
    Authors: Iaci JF, Ganguly A, Finklestein SP, Parry TJ, Ren J, Saha S, Sietsma DK, Srinivas M, Vecchione AM, Caggiano AO
    Neuropharmacology, 2010;59(7):640-9.  2010
  65. Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
    Authors: Meyer-Siegler KL, Cox J, Leng L, Bucala R, Vera PL
    Cancer Lett., 2010;290(1):49-57.  2010
  66. Oxidized alpha1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema.
    Authors: Li Z, Alam S, Wang J, Sandstrom CS, Janciauskiene S, Mahadeva R
    Am. J. Physiol. Lung Cell Mol. Physiol., 2009;297(2):L388-400.  2009
  67. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
    Authors: Mouawad R, Spano JP, Comperat E, Capron F, Khayat D
    Eur. J. Cancer, 2009;45(8):1407-14.  2009
  68. Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis.
    Authors: Kim JY, Kwok SK, Hur KH, Kim HJ, Kim NS, Yoo SA, Kim WU, Cho CS
    Clin. Exp. Immunol., 2008;152(2):328-35.  2008
  69. Nanobacteria are mineralo fetuin complexes.
    Authors: Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, Rolain JM, Fourquet P, Campagna B, La Scola B, Mege JL, Mansuelle P, Lechevalier E, Berland Y, Gorvel JP, Renesto P
    PLoS Pathog., 2008;4(2):e41.  2008
  70. Facilitated in vivo synthesis of ribonucleic acid and protein via T7 RNA polymerase.
    Authors: Wang TH, Yu SH, Au LC
    Anal. Biochem., 2008;375(1):97-104.  2008
  71. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity.
    Authors: Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA, Collins C, Viala J, Ferrero RL, Girardin SE, Philpott DJ
    Immunity, 2007;26(4):445-59.  2007
  72. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation.
    Authors: Rabe B, Chalaris A, May U, Waetzig GH, Seegert D, Williams AS, Jones SA, Rose-John S, Scheller J
    Blood, 2007;111(3):1021-8.  2007
  73. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.
    Authors: Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding CA, Jones SA, Rose-John S, Scheller J
    Blood, 2007;110(6):1748-55.  2007
  74. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report.
    Authors: Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, Pattengill J, Hayden JM
    Chest, 2007;132(1):58-63.  2007
  75. Mycobacterium tuberculosis antigens specifically modulate CCR2 and MCP-1/CCL2 on lymphoid cells from human pulmonary hilar lymph nodes.
    Authors: Arias MA, Jaramillo G, Lopez YP, Mejia N, Mejia C, Pantoja AE, Shattock RJ, Garcia LF, Griffin GE
    J. Immunol., 2007;179(12):8381-91.  2007
  76. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells.
    Authors: Infantino S, Moepps B, Thelen M
    J. Immunol., 2006;176(4):2197-207.  2006
  77. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
    Authors: Yi C, Sun X, Ye J, Ding L, Liu M, Yang Z, Lu X, Zhang Y, Ma L, Gu W, Qu A, Xu J, Shi Z, Ling Z, Sun B
    Cell Mol Immunol, 0;17(6):621-630.  0
  78. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
    Authors: Evans C, Miners J, Piva G, Willis C, Heard D, Kidd E, Good M, Kehoe P
    Acta Neuropathol, 0;139(3):485-502.  0
  79. VSIG-3 as a ligand of VISTA inhibits human T-cell function.
    Authors: Wang J, Wu G, Manick B, Hernandez V, Renelt M, Erickson C, Guan J, Singh R, Rollins S, Solorz A, Bi M, Li J, Grabowski D, Dirkx J, Tracy C, Stuart T, Ellinghuysen C, Desmond D, Foster C, Kalabokis V
    Immunology, 0;156(1):74-85.  0

FAQs

No product specific FAQs exist for this product, however you may

View all ELISA FAQs

Supplemental ELISA Products

Reviews for Streptavidin-HRP

Average Rating: 4.8 (Based on 18 Reviews)

5 Star
83.33%
4 Star
16.67%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Streptavidin-HRP?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Streptavidin-HRP
By Anonymous on 11/18/2021
Application:

Worked great for ELISA assay. Provides acceptable signal to noise ratio consistently.


Streptavidin-HRP
By Anonymous on 09/28/2021
Application:

Streptavidin-HRP
By Anonymous on 09/10/2021
Application:

Semi-quantification of CD63 by ELISA, in different fractions of ion exchange chromatography isolated EV.


Streptavidin-HRP
By Anonymous on 05/13/2021
Application:

Streptavidin-HRP
By Anonymous on 10/23/2020
Application:

Streptavidin-HRP
By Anonymous on 02/26/2020
Application:

Used Strep-HRP to develop an IL-25 ELISA.
Works as expected at the suggested concentration.
Very nice results, standards and control show up nicely.


Streptavidin-HRP
By Anonymous on 01/22/2020
Application:

1:200 dilution in 1% milk used for wesern blot of biotinylated viral protein.
15% gel, wet transfer, overnight incubation with Streptavidin-HRP.
Only specific bands were seen and no background at all.
Highly recommended


Streptavidin-HRP
By Anonymous on 11/06/2019
Application:

Streptavidin-HRP
By Anonymous on 03/29/2019
Application:

Used SA-HRP 1:200 for 30 min to compared a in-house biotinylated antibody to the unconjugated with direct ELISA


Streptavidin-HRP
By Anonymous on 11/26/2018
Application:

Streptavidin-HRP
By Anonymous on 11/06/2018
Application:

Streptavidin-HRP
By Anonymous on 08/17/2018
Application:

Streptavidin-HRP
By Anonymous on 04/16/2018
Application:

We used this Ab for the Elisa in a 1:200 dilution, it works very well, showed no background.


Streptavidin-HRP
By Anonymous on 12/18/2017
Application:

Streptavidin-HRP (set of 5 vials enough for 75 plates total)
By Anonymous on 12/05/2017
Application:

Streptavidin-HRP (set of 5 vials enough for 75 plates total)
By Anonymous on 07/20/2017
Application:

Standard ELISA protocol observed for concentration analysis


Streptavidin-HRP (set of 5 vials enough for 75 plates total)
By Anonymous on 12/21/2016
Application:

Western blot of biotinated molecule.1:1000dilution of the product in BSA


Streptavidin-HRP (set of 5 vials enough for 75 plates total)
By Anonymous on 06/02/2016
Application: